Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 07, 2025, titled "Press Release - Financial Results Q2".
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Torrent Pharmaceuticals has notified the stock exchange about a press release dated November 7, 2025, covering its Q2 financial results. The filing itself is only an intimation and does not include the actual numbers or detailed performance. Investors would need to refer to the full press release or the Q2 results filing for revenue, profit, and segment-level details. This is essentially a procedural disclosure required before the detailed financial results are released. Watch for the detailed Q2 results announcement that should follow shortly.
No direct price impact from this intimation itself, but the underlying Q2 results (to be released shortly) could move the stock depending on whether they beat or miss market expectations.